New york: Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm-firmenich, a leading ingredient manufacturer serving regulated pharmaceutical markets worldwide.

According to BERNAMA News Agency, through this partnership, Medisca will make a portfolio of pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) available to U.S. compounding professionals. This collaboration aims to expand access to ingredients manufactured within European cGMP environments and supported by established quality systems and documentation standards.